{"skill":{"slug":"amgen-biotech","displayName":"Amgen Biotech","summary":"Amgen pioneers biotech with key drugs EPO and Neupogen, focusing on oncology, cardiovascular, and inflammation therapies with biologics-based revenue.","tags":{"latest":"1.0.0"},"stats":{"comments":0,"downloads":106,"installsAllTime":0,"installsCurrent":0,"stars":0,"versions":1},"createdAt":1778187913312,"updatedAt":1778492872010},"latestVersion":{"version":"1.0.0","createdAt":1778187913312,"changelog":"- 初始版本发布，提供 Amgen 公司的详细介绍和发展历史。\n- 涵盖 EPO 与 Neupogen 两款标志性药物的商业化与行业影响。\n- 描述 Amgen 的商业模式、护城河分析及关键财务与运营数据。\n- 增加有趣事实，包括公司名称由来及 EPO 相关历史事件。","license":"MIT-0"},"metadata":null,"owner":{"handle":"hanxueyuan","userId":"s17eht14r6y7ztwaw37n96ka7583eghn","displayName":"hanxueyuan","image":"https://avatars.githubusercontent.com/u/16717383?v=4"},"moderation":null}